The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major caveat: They don’t work for everyone. Some people experience profound ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

A couple of decades ago, GLP-1 drugs were a specialised treatment for type-2 diabetes but, fast-forward to today, and they have become much more widespread, being sold to help people with obesity and ...

This surge is driven by national immunization programs transitioning from cold-chain-dependent liquid vials and syringes to thermostable, self-administrable solid-dose transdermal platforms. NEWARK, ...

Researchers also noted a reduced risk of self-harm among people taking GLP-1 medications Angelique Brenes is a writer-reporter at PEOPLE. She joined PEOPLE in 2026. Her work has previously appeared on ...

A new study finds quitting GLP-1 drugs like Ozempic can reverse health gains and increase heart health risks. Patients who stopped taking the medication saw a higher risk for heart attack, stroke, or ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems. However, if people stop taking the medication, those heart ...

Researchers are testing a tiny microneedle patch that could deliver vaccines without a standard needle and early animal studies suggest it may trigger a stronger immune response than injections.

Cyndy Dowling struggled with her weight for decades until she found what she thought was a lifelong solution: a monthly injection of one of the popular new weight-loss drugs. The 69-year-old easily ...

Researchers from Nanjing Drum Tower Hospital, Southeast University, and Wenzhou Medical University have developed a novel microneedle patch that combines MXene hydrogel with nitric oxide (NO) and ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

This could be a game-changer for people who want fewer jabs with needles. MIT researchers developed a microneedle patch to sample immune response noninvasively. The patch provides an alternative to ...